ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001104.1|Myxovirescin_1 # 1 # 744 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.645	BGC0001104.1|Myxovirescin_1 	1	744	-	Loose	600	25.0238	Acinetobacter baumannii AmvA	33.33	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGCCGGTGGTCACGCTCCATGAGGTGGAGGAGGGGGTGGCGCAGATCACCCTGGTGGATCGCGAGAACAAGAACATGTTCAGCGAGCAGCTCGTGCGCGAGCTCATCACCGTGTTCGGCAAGGTGAATGGAAACGAGCGCTACCGCGCGGTGGTGCTCACCGGCTACGACACCTACTTCGCGCTCGGCGGGACCAAGGCCGGCCTGCTGTCCATCTGCGACGGCATCGGCTCCTTCAACGTCACCAACTTCTACAGCCTCGCGCTGGAGTGCGACATCCCGGTGATTTCCGCCATGCAGGGACATGGCGTAGGCGGCGGGTTCGCGATGGGGCTGTTCGCGGACTTCGTGGTCCTGAGCCGGGAGAGCGTCTACACGACGAACTTCATGCGCTACGGCTTCACGCCGGGGATGGGCGCCACGTACATCGTGCCGAAGCGGCTGGGGTACTCGCTCGGGCATGAGCTCCTGCTCAACGCCAGGAACTACCGCGGCGCCGACCTGGAGAAGCGGGGCGTGCCTTTTCCGGTGTTGCCGCGCAAGGAAGTCTTGCCCCACGCCTACGAGATTGCGAGGGACCTGGCCGCGAAACCTCGGCTGTCGCTCGTGACGCTCAAGCGGCACCTGGTTCGCGACATCCGCCGAGAGCTTCCGGACGTCATCGAGCGTGAGCTGGAGATGCACGGCATCACCTTCCATCACGACGACGTGAGGAGGCGCATCGAGCAGCTGTTCCTCTGA	MAPVVTLHEVEEGVAQITLVDRENKNMFSEQLVRELITVFGKVNGNERYRAVVLTGYDTYFALGGTKAGLLSICDGIGSFNVTNFYSLALECDIPVISAMQGHGVGGGFAMGLFADFVVLSRESVYTTNFMRYGFTPGMGATYIVPKRLGYSLGHELLLNARNYRGADLEKRGVPFPVLPRKEVLPHAYEIARDLAAKPRLSLVTLKRHLVRDIRRELPDVIERELEMHGITFHHDDVRRRIEQLFL	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	50.20	gnl|BL_ORD_ID|2775|hsp_num:0	3280		
BGC0001104.1|Myxovirescin_2 # 759 # 1547 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.672	BGC0001104.1|Myxovirescin_2 	759	1547	-	Loose	750	25.7942	bmr	31.71	3003007	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; nucleoside antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAAGCCGCTTCCCCTCCGCACCGCGACTACCAGACGCTCCGGGTCCGCTTCGAGGCGCAGACCTGTTTTCTCCAGCTCCACCGGCCGGATGCGGACAACACCATCAGCCGCACGCTGATTGACGAGTGCCAGCAGGTGCTCACGTTATGTGAGGAGCACGCCACCACGGTGGTGCTCGAAGGCCTGCCACACGTGTTCTGCATGGGCGCGGATTTTCGAGCCATCCACGACCGGGTCGACGACGGCCGCCGGGAGCAAGGCAACGCGGAGCAGCTGTACCGGCTGTGGCTGCAACTGGCGACAGGCCCCTACGTGACGGTCGCCCATGTGCAGGGCAAGGCCAACGCGGGCGGCCTGGGCTTCGTCGCCGCGTGCGACATCGTGCTGGCAAAGGCGGAGGTCCAGTTCAGTCTCTCCGAGCTGCTGTTCGGGCTGTTCCCCGCCTGCGTGATGCCGTTCCTCGCCCGGCGAATCGGCATCCAGCGGGCGCACTACCTGACGCTGATGACGCGGCCCATCGACGCGGCCCAGGCGCTGAGCTGGGGGTTGGCGGACGCGGTGGACGCCGATAGCGAGAAGCTGTTGCGGCTCCACTTGCGCAGGCTGCGGTGCCTGTCGAAGCCAGCGGTGACCCAGTACAAGAAGTACGCCTCCGAGCTGGGCGGCCAGCTGCTCGCGGCCATGCCCCGGGCCATCTCCGCCAATGAGGCGATGTTCTCCGACCGCGCCACGCTGGAAGCCATCCATCGCTACGTGGAGACAGGCCGACTCCCATGGGAATCATGA	MQAASPPHRDYQTLRVRFEAQTCFLQLHRPDADNTISRTLIDECQQVLTLCEEHATTVVLEGLPHVFCMGADFRAIHDRVDDGRREQGNAEQLYRLWLQLATGPYVTVAHVQGKANAGGLGFVAACDIVLAKAEVQFSLSELLFGLFPACVMPFLARRIGIQRAHYLTLMTRPIDAAQALSWGLADAVDADSEKLLRLHLRRLRCLSKPAVTQYKKYASELGGQLLAAMPRAISANEAMFSDRATLEAIHRYVETGRLPWES	MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPIAGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIADITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTLREPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTASDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILLVTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNYPFYFATVTLAIGIALTIAWKAPAHLKAST	67.35	gnl|BL_ORD_ID|1183|hsp_num:0	1256		
BGC0001104.1|Myxovirescin_4 # 2870 # 4834 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0001104.1|Myxovirescin_4 	2870	4834	-	Loose	500	25.409	sul1	40.54	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGTCGATTCAGTGTCGAAACAGGCACGGCGGAAGGTGTTTCTTTTTTCCGGCCAGGGCACCCAGTCGTACTTCATGGCCAAGGAGCTGTTTGACACCCAGACGGGGTTCAAGCGGCAGCTGCTGGAGCTGGACGAGCAATTCAAGCAGCGGCTGGGGCACTCGATTCTCGAGCGAATCTATGACGCGCGCGCCGCGCGGTTGGATCCGCTCGACGATGTCCTGGTGTCCTTTCCCGCCATCTTCATGATTGAGCATGCGCTGGCGCGGCTGCTCATCGACCGGGGTATCCAGCCGGACGCTGTCGTGGGCGCCAGCATGGGCGAGGTGGCGGCGGCGGCGATTGCGGGCGCAATCTCAGTGGACGCGGCCGTGGCCCTGGTGGCGGCGCAGGCCCAGCTCTTTGCCCGTACGGCGCCGCGGGGCGGCATGCTCGCGGTGCTTCACGAACTGGAAGCCTGCCGGGGCTTCACGTCCGTCGCGCGGGATGGCGAGGTTGCAGCCATCAACTACCCGTCGAACTTCGTCCTTGCGGCGGATGAGGCGGGCCTGGGACGGATTCAGCAGGAACTCTCCCAACGCTCGGTGGCGTTCCACCGGTTGCCGGTGCGCTACCCCTTTCATTCCTCGCACCTGGACCCGCTGAGGGAGGAGTACCGAAGCCGCGTCCGCGCGGATTCGCTGACGTGGCCGCGAATCCCCATGTACTCGTGCACCACCGCGAACCGGGTGCACGACCTGCGCAGCGACCACTTCTGGAACGTGGTCCGCGCGCCCATCCAGCTGTACGACACCGTCCTGCAACTGGAGGGGCAGGGCGGCTGCGACTTCATCGACGTCGGCCCCGCCGCGTCCTTCGCGACCATCATCAAGCGCATCCTCGCGCGGGACTCCACGTCACGGCTCTTCCCGTTGCTCAGCCCCTTCTCCCGCATCGACCGGGAGCTCGATGGGGTGACGCGGAGCTGCGCGATGACGGAGGCGCCCGCACCCAGGGCGCCTGCGCAGGTGCCGCCGCCGCCGAGCTCGCCCTGGGCGCTGCACACCCGAGGAGCGGCGAGCGCGCCGGTGAATGCCCGCAAGGCCGCGCTCTTCCCGGGGCAGGGCTCGCAGGAGCGCGGCATGGGGGCCGCGCTCTTCGACGAGTTCCCGGACCTGACGGACATCGCCGACGCCATCCTGGGGTATTCCATCAAGCGTCTCTGTTTGGAGGACCCAGGCAAGGAGCTGGCGCAGACGCAGTTCACCCAGCCGGCGTTGTACGTGGTGAACGCGCTCAGCTACCTGAAGCGGCTGCGTGAAGGAGCGGAGCAGCCGGCCTTCGTCGCGGGCCACAGCCTGGGCGAGTACAACGCGCTGCTGGTCGCGGGGGCCTTCGACTTCGAGACGGGACTGCGGCTGGTGAAGCGGCGGGGCGAACTCATGAGCGGCGCGTCCGGAGGGACCATGGCCGCGGTGGTGGGCTGTGATGCCGTGGCCGTGGAACAGGTCCTTCGAGACCGTCAGCTGACCAGTCTGGATATCGCCAACATCAACTCGCCCGACCAGATTGTGGTCTCCGGACCGGCGCAGGACATCGAGCGGGCACGGCAGTGTTTCGTGGACCGTGGCGCGCGGTACGTTCCGCTCAACGTGCGAGCGCCGTTTCACTCGCGCTACATGCAGCCGGCCGCCAGCGAGTTCGAGCGCTTCCTGTCTCAGTTCCAGTACGCGCCGCTCCGGTGCGTGGTCATCTCCAACGTCACGGGCCGACCTTACGCTCATGACAACGTGGTGCAGGGGCTGGCTCTGCAACTGCGCAGCCCGGTGCAGTGGACGGCCACCGTCCGCTACCTCCTGGAACAGGGCGTGGAGGACTTCGAGGAGCTGGGCCCCGGCCGCGTGCTGACCCGCCTCATCACCGCGAACAAGCGGGGCGCCCCCGCACCGGCCACCGCCGCGCCCGCGAAGTGGGCGAATGCCTGA	MVDSVSKQARRKVFLFSGQGTQSYFMAKELFDTQTGFKRQLLELDEQFKQRLGHSILERIYDARAARLDPLDDVLVSFPAIFMIEHALARLLIDRGIQPDAVVGASMGEVAAAAIAGAISVDAAVALVAAQAQLFARTAPRGGMLAVLHELEACRGFTSVARDGEVAAINYPSNFVLAADEAGLGRIQQELSQRSVAFHRLPVRYPFHSSHLDPLREEYRSRVRADSLTWPRIPMYSCTTANRVHDLRSDHFWNVVRAPIQLYDTVLQLEGQGGCDFIDVGPAASFATIIKRILARDSTSRLFPLLSPFSRIDRELDGVTRSCAMTEAPAPRAPAQVPPPPSSPWALHTRGAASAPVNARKAALFPGQGSQERGMGAALFDEFPDLTDIADAILGYSIKRLCLEDPGKELAQTQFTQPALYVVNALSYLKRLREGAEQPAFVAGHSLGEYNALLVAGAFDFETGLRLVKRRGELMSGASGGTMAAVVGCDAVAVEQVLRDRQLTSLDIANINSPDQIVVSGPAQDIERARQCFVDRGARYVPLNVRAPFHSRYMQPAASEFERFLSQFQYAPLRCVVISNVTGRPYAHDNVVQGLALQLRSPVQWTATVRYLLEQGVEDFEELGPGRVLTRLITANKRGAPAPATAAPAKWANA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	234.41	gnl|BL_ORD_ID|1005|hsp_num:0	1070		
BGC0001104.1|Myxovirescin_5 # 4872 # 6299 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.650	BGC0001104.1|Myxovirescin_5 	4872	6299	-	Loose	1000	30.8018	msbA	48.0	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGGACCTCAGAGCCAGTTGAGCCGGACCACGCCTTGTCAAAACCACCGCCTGTCGCGCCCGTCGGCGCCCAGGCACTGCCTCGCGGTCCGGCAATGCCCGGCATCGCGCAGTTGATGATGTTGTTCCTGCGGCCCACGGAGTTCCTGGACCGCTGCGCCGCCCGGTACGGTGACACCTTCACCCTCAAGATTCCGGGGACGCCGCCGTTCATCCAGACCAGCGATCCCGCCTTGATCGAGGTCATCTTCAAGGGTGACCCGGACCTCTTCCTCGGAGGGAAGGCGAACAACGGGTTGAAGCCGGTGGTGGGTGAGAACTCGCTGCTGGTGTTGGACGGGAAGCGGCACCGGCGTGATCGCAAGCTCATCATGCCCACCTTCCTGGGTGAACGGATGCATGCGTATGGCTCGGTCATCCGGGACATCGTCAATGCGGCGCTTGACCGGTGGCCCGTCGGGAAGCCGTTCGCGGTCCATGAAGAGACGCAGCAGATCATGCTGGAGGTGATTCTCCGGGTGATTTTCGGCCTGGAGGACGCCCGGACCATTGCCCAGTTCCGGCACCACGTGCACCAGGTGCTCAAGCTGGCCCTGTTCCTGTTCCCGAACGGGGAGGGCAAGCCCGCCGCCGAGGGCTTCGCGCGGGCCGTGGGCAAGGCGTTTCCCTCCCTGGACGTGTTCGCGTCGCTGAAGGCGATTGACGACATCATCTACCAGGAGATTCAGGACCGCCGGAGCCAGGACATCAGCGGGCGGCAGGACGTGCTCTCGCTGATGATGCAGTCGCACTACGACGACGGCTCCGTGATGACGCCCCAGGAGCTGCGCGACGAGCTGATGACGCTGCTGATGGCGGGCCACGAGACGAGCGCGACCATCGCCGCGTGGTGCGTCTACCACCTCTGCCGTCACCCGGATGCGATGGGCAAGCTGCGTGAGGAGATCGCGGCCCACACGGTGGACGGCGTGCTGCCGCTGGCGAAGATCAACGAGCTGAAGTTCCTGGATGCCGTGGTCAAGGAGACGATGCGCATCACGCCCGTCTTCAGCCTGGTGGCTCGCGTGCTCAAGGAGCCACAGACCATTGGCGGAACGACGTACCCGGCGAACGTGGTGCTGTCGCCCAACATCTACGGCACGCACCATCGCGCGGACCTGTGGGGAGACCCGAAGGTCTTTCGGCCAGAGCGTTTCCTGGAGGAGCGGGTGAATCCGTTCCACTACTTCCCCTTCGGAGGGGGCATCCGGAAGTGCATCGGGACGAGCTTCGCCTACTACGAGATGAAGATCTTCGTCTCGGAGACGGTGCGCCGCATGCGCTTCGATACCAGGCCCGGCTACCACGCGAAGGTGGTGCGCCGGAGCAACACGCTGGCGCCGTCTCAGGGCGTGCCCATCATCGTCGAGTCGCGGCTGCCGAGCTGA	MGTSEPVEPDHALSKPPPVAPVGAQALPRGPAMPGIAQLMMLFLRPTEFLDRCAARYGDTFTLKIPGTPPFIQTSDPALIEVIFKGDPDLFLGGKANNGLKPVVGENSLLVLDGKRHRRDRKLIMPTFLGERMHAYGSVIRDIVNAALDRWPVGKPFAVHEETQQIMLEVILRVIFGLEDARTIAQFRHHVHQVLKLALFLFPNGEGKPAAEGFARAVGKAFPSLDVFASLKAIDDIIYQEIQDRRSQDISGRQDVLSLMMQSHYDDGSVMTPQELRDELMTLLMAGHETSATIAAWCVYHLCRHPDAMGKLREEIAAHTVDGVLPLAKINELKFLDAVVKETMRITPVFSLVARVLKEPQTIGGTTYPANVVLSPNIYGTHHRADLWGDPKVFRPERFLEERVNPFHYFPFGGGIRKCIGTSFAYYEMKIFVSETVRRMRFDTRPGYHAKVVRRSNTLAPSQGVPIIVESRLPS	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	81.62	gnl|BL_ORD_ID|2242|hsp_num:0	2423		
BGC0001104.1|Myxovirescin_6 # 6348 # 6863 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.622	BGC0001104.1|Myxovirescin_6 	6348	6863	-	Loose	400	24.6386	MUS-2	52.63	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGAACACTCCTTCCTTGACGAACTGGCCTGCCCGCCTGGGCTATCTCCTTGCCGTTGGCGGCGCATGGTTCGCGGCCGATCAAGTCACCAAACAGATGGCGCGCGACGGGGCGAAAAGGCCCGTCGCGGTCTTCGATAGCTGGTGGCACTTCCACTACGTGGAGAACCGAGCGGGTGCGTTCGGTCTGTTCTCCAGCTTCGGCGAAGAGTGGCGCATGCCTTTCTTCTACGTCGTGGGCGCCATCTGCATCGTGTTGCTGATTGGCTACTACTTCTACACGCCGCCGACGATGAAGCTCCAGCGCTGGTCGCTGGCGACGATGATTGGCGGCGCGTTGGGCAACTACGTGGACCGGGTGCGCCTGCGCTACGTGGTGGATTTCGTGTCATGGCACGTGGGGGACCGCTTCTATTGGCCCTCCTTCAACATCGCGGACACAGCGGTAGTCGTAGGGGCCGCCCTGATGATCCTGGAGTCGTTCCGCGAGCCGCGTCAGCAGTTGTCTCCCGGATAG	MNTPSLTNWPARLGYLLAVGGAWFAADQVTKQMARDGAKRPVAVFDSWWHFHYVENRAGAFGLFSSFGEEWRMPFFYVVGAICIVLLIGYYFYTPPTMKLQRWSLATMIGGALGNYVDRVRLRYVVDFVSWHVGDRFYWPSFNIADTAVVVGAALMILESFREPRQQLSPG	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	69.51	gnl|BL_ORD_ID|2160|hsp_num:0	2328		
BGC0001104.1|Myxovirescin_7 # 6891 # 8141 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.667	BGC0001104.1|Myxovirescin_7 	6891	8141	-	Loose	300	28.8758	AAC(3)-VIa	32.61	3002540	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGGCTGAGCGGGTTCCCGGCGGAGTCGGCATCGAGGCCATCAACGCCTACGGCGGCGCCGCCTCCATTCCGGTGTTGGACTTGTTCCGGGGCCGGCGGCTGGACCCCGAGCGATTCTCCAACCTGATGATGCAGGAGCGCGGCGTCGCGCTGCCGTTCGAGGACCCCGTCACCAACGCGGTCAATGCGGCGCGGCCCATCCTGGACGCGATGTCGCCCGAGGCCCGGGAGCGCATCGAGCTCCTGGTCACCTCGAGCGAGTCCGGCGTGGACTTCAGCAAGTCCATCTCCTCGTATGCGCACGAGCACCTGGGGCTGAGCCGCCACTGCCGGTTCCTGGAGGTGAAGCAGGCGTGTTACGCCGCCACCGGAGCGCTCCAGCTAGCGCTGGGCTACATCGCGTCGGGCGTGTCACCGGGGGCCAAGGCCCTGGTGATTGCCACGGACGTGACGCTGGTGGACGAGAGCGGTCTGTACTCCGAGCCGGCGATGGGCACCGGCGGCGTCGCCGTGCTGCTGGGCGACGAGCCGCGCGTGATGAAGATGGACCTGGGAGCGTTCGGCAACTACAGCTACGACGTCTTCGACACCGCGCGGCCCTCGCCGGAGATTGATATCGGCGACGTGGACCGGTCGCTCTTCACGTACCTGGACTGCCTCAAGCACAGCTTCGCCGCGTATGGCCGCCGGGTGGACGGTGTCGACTTCGTGTCGACGTTCGACTACCTGGCGATGCACACGCCGTTCGCCGGACTGGTGAAGGCCGGGCACCGCAAGATGATGCGCGAGCTCACCCCGTGCGACGTGGACGAAATCGAAGCGGACTTCGGCCGGCGCGTGAAGCCGTCACTGCAGTACCCGAGTCTGGTCGGGAACCTGTGCTCCGGCTCCGTGTACCTGAGCCTGTGCAGCATCATCGACACCATCAAGCCCGAGCGGTCCGCTCGGGTGGGAATGTTCTCCTATGGGTCGGGTTGCTCGTCGGAGTTCTTCAGCGGCGTCATCGGCCCGGAGTCCGTGTCCGCGCTAGCTGGGTTGGACATCGGTGGCCACCTCCGGGGGCGCCGCCAGCTCACGTTCGACCAATATGTCGAATTGCTGAAAGAGAACCTTCGCTGTCTGGTTCCAACGAAGAACCGGGACGTGGACGTGGAGCGCTACCTCCCGCTGGTGACGCGGACGGCGAGCCGCCCGCGCATGCTCGCCTTGCGAAGGGTCGTGGACTATCATCGTCAGTACGAGTGGGTGTAG	MAERVPGGVGIEAINAYGGAASIPVLDLFRGRRLDPERFSNLMMQERGVALPFEDPVTNAVNAARPILDAMSPEARERIELLVTSSESGVDFSKSISSYAHEHLGLSRHCRFLEVKQACYAATGALQLALGYIASGVSPGAKALVIATDVTLVDESGLYSEPAMGTGGVAVLLGDEPRVMKMDLGAFGNYSYDVFDTARPSPEIDIGDVDRSLFTYLDCLKHSFAAYGRRVDGVDFVSTFDYLAMHTPFAGLVKAGHRKMMRELTPCDVDEIEADFGRRVKPSLQYPSLVGNLCSGSVYLSLCSIIDTIKPERSARVGMFSYGSGCSSEFFSGVIGPESVSALAGLDIGGHLRGRRQLTFDQYVELLKENLRCLVPTKNRDVDVERYLPLVTRTASRPRMLALRRVVDYHRQYEWV	MTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQTLVDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAINEFIRTYPGCRRTAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIGAGPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPDAVERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD	139.13	gnl|BL_ORD_ID|1038|hsp_num:0	1105		
BGC0001104.1|Myxovirescin_8 # 8134 # 8397 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.663	BGC0001104.1|Myxovirescin_8 	8134	8397	-	Loose	2200	22.7126	Bifidobacterium bifidum ileS conferring resistance to mupirocin	66.67	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	GTGGGTGAGCCGATGACAGACGAACAAATCCGCGGAGTCGTGCACCAGTCCATCGTGCGCGTCCTGCCCCGCGTGCGCTCCAACGAGATTGCGGGCCACTTGAACCTCCGCGAGCTGGGCGCGGACTCCGTGGACCGGGTCGAGATTCTCACGTCCATCCTGGACAGCCTGCGGCTGCAGAAGACGCCACTGGCGAAGTTCGCCGACATCCGCAACATCGACGCGCTGGTGGCGTTCCTGGCCGGTGAGGTCGCGGGTGGCTGA	MGEPMTDEQIRGVVHQSIVRVLPRVRSNEIAGHLNLRELGADSVDRVEILTSILDSLRLQKTPLAKFADIRNIDALVAFLAGEVAGG	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	7.86	gnl|BL_ORD_ID|2107|hsp_num:0	2278		
BGC0001104.1|Myxovirescin_10 # 9390 # 10652 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.673	BGC0001104.1|Myxovirescin_10 	9390	10652	-	Loose	2200	27.335	Bifidobacterium bifidum ileS conferring resistance to mupirocin	36.36	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGGGGCCGGTCGGGATTGAAGCCATGAATGCCTACTGTGGCATCGCCAGGTTGGATGTGTTGCAGCTGGCGACCCACCGTGGCCTGGACACCTCCCGCTTCGCGAACCTGCTCATGGAGGAGAAGACCGTCCCGCTCCCCTATGAGGACCCTGTCACCTACGGCGTGAATGCCGCCCGGCCCATCCTGGACCAGTTGACCGCGGCGGAACGGGACAGCATCGAGCTGCTGGTGGCTTGCACGGAGTCCTCGTTCGACTTCGGCAAGGCCATGAGCACCTACCTGCACCAGCACCTGGGGCTGAGCCGCAACTGCCGGCTCATCGAGCTCAAGAGCGCCTGCTACTCCGGGGTCGCCGGGCTGCAGATGGCCGTCAACTTCATCCTGTCCGGCGTGTCGCCGGGGGCCAAGGCCCTGGTGGTGGCCTCCGACCTGTCGCGCTTCTCCATCGCCGAAGGGGGAGATGCCTCCACGGAGGACTGGTCCTTCGCGGAGCCGAGCTCGGGTGCGGGCGCGGTGGCCATGCTGGTGAGCGACACGCCCCGGGTGTTCCGCGTCGACGTGGGGGCGAACGGCTACTACGGCTACGAGGTGATGGATACCTGCCGCCCGGTGGCGGACAGCGAAGCGGGAGACGCGGACCTGTCGCTCCTCTCGTACCTGGACTGCTGTGAGAACGCCTTCCGGGAGTACACCCGCCGCGTCCCCGCGGCGAACTACGCGGAGAGCTTCGGCTACCTCGCCTTCCACACGCCGTTTGGCGGCATGGTGAAGGGCGCCCACCGCACGATGATGCGCAAGTTCTCCGGCAAGAACCGCGGGGACATCGAAGCGGACTTCCAGCGGCGAGTGGCCCCCGGGCTGACCTACTGCCAGCGCGTGGGGAACATCATGGGCGCGACGATGGCGCTCTCGCTCCTCGGGACCATCGACCACGGCGACTTCGCCACCGCGAAGCGGATTGGCTGCTTCTCGTATGGCTCGGGGTGCAGCTCGGAGTTCTTCAGCGGCGTGGTGACGGAGGAAGGGCAGCAGCGGCAGCGCGCCCTGGGGCTGGGAGAAGCGCTGGGGCGCCGGCAGCAGCTCTCCATGCCGGATTACGACGCGCTGCTGAAGGGGAACGGCCTGGTGCGCTTCGGGACCCGGAACGCCGAGCTGGATTTCGGTGTCGTCGGCAGCATCCGGCCGGGCGGGTGGGGCAGGCCCTTGCTCTTCTTGTCGGCGATTCGTGACTTCCATCGCGACTACCAATGGATTTCCTAG	MGPVGIEAMNAYCGIARLDVLQLATHRGLDTSRFANLLMEEKTVPLPYEDPVTYGVNAARPILDQLTAAERDSIELLVACTESSFDFGKAMSTYLHQHLGLSRNCRLIELKSACYSGVAGLQMAVNFILSGVSPGAKALVVASDLSRFSIAEGGDASTEDWSFAEPSSGAGAVAMLVSDTPRVFRVDVGANGYYGYEVMDTCRPVADSEAGDADLSLLSYLDCCENAFREYTRRVPAANYAESFGYLAFHTPFGGMVKGAHRTMMRKFSGKNRGDIEADFQRRVAPGLTYCQRVGNIMGATMALSLLGTIDHGDFATAKRIGCFSYGSGCSSEFFSGVVTEEGQQRQRALGLGEALGRRQQLSMPDYDALLKGNGLVRFGTRNAELDFGVVGSIRPGGWGRPLLFLSAIRDFHRDYQWIS	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	37.94	gnl|BL_ORD_ID|2107|hsp_num:0	2278		
BGC0001104.1|Myxovirescin_11 # 10662 # 10901 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.600	BGC0001104.1|Myxovirescin_11 	10662	10901	-	Loose	2000	27.335	adeB	47.83	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACAAGAGAATTATTTTCGACATCGTCACCAGCAGTGTTCGGGAGGTGGTACCCGAACTCGAATCACATCCGTTCGAGCCGGAGGATGACCTGGTCGGACTGGGCGCGAACTCGCTCGACCGCGCCGAAATCGTCAACCTCACGCTGGAGAAGCTGGCGCTCAACATCCCCCGGGTCGAGCTGATTGACGCGAAGACCATTGGCGGGCTGGTGGACGTCCTTCACGCGAGGCTGTGA	MDKRIIFDIVTSSVREVVPELESHPFEPEDDLVGLGANSLDRAEIVNLTLEKLALNIPRVELIDAKTIGGLVDVLHARL	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	7.63	gnl|BL_ORD_ID|817|hsp_num:0	866		
BGC0001104.1|Myxovirescin_12 # 10975 # 11481 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.631	BGC0001104.1|Myxovirescin_12 	10975	11481	-	Loose	250	25.0238	arr-1	38.1	3002846	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGCCTGGGCCGCGGTGTGCTGAGAACGATTGGGTTGCATTGCTCGTCCGCGTCAATCACGAGAAAGTGGCTGCCGCTCAGTTGGGGAAACACGGCTACGAGTTCTTCCTGCCGACGTACACGCCTCCCAAGTCCTCGGGTGTGAAGGCGAAGCTTCCGCTCTTCCCCGGGTACCTTTTCTGTCGTTACCAGCCGCTCAATCCGTACCGCATCGTCCGGGCGCCCGGGGTCATCCGGCTGCTCGGAGGTGACGCGGGGCCGGAAGCCGTGCCCGCACAGGAATTGGAGGCCATCCGCCGGGTCGCGGATTCGGGTGTCTCTTCCAATCCCTGTGACTATCTGCGGGTGGGGCAGCGCGTGCGCATCATCGAAGGGCCCCTGACAGGTCTGGAAGGAAGTCTGGTGACGAGCAAGAGCCAACTCCGGTTCATTGTCTCCGTGGGGCTGCTACAGCGCTCGGTGTCCGTGGAGGTGAGCGCCGAGCAACTGGAACCGATCACCGACTGA	MPGPRCAENDWVALLVRVNHEKVAAAQLGKHGYEFFLPTYTPPKSSGVKAKLPLFPGYLFCRYQPLNPYRIVRAPGVIRLLGGDAGPEAVPAQELEAIRRVADSGVSSNPCDYLRVGQRVRIIEGPLTGLEGSLVTSKSQLRFIVSVGLLQRSVSVEVSAEQLEPITD	MVANPPKPFEVHESGAYLHGTKADLKVGDRLVPGRESNFEAGRIMKHVYITQTLDAAVWGAELAVGEGRGRIYIVEPEGEIEDDPNVTDKKLPGNPTRSYRTREPVRIVGELTDWEGHSPEQIAAMREGLEDLRRKGLAVIYD	117.48	gnl|BL_ORD_ID|1844|hsp_num:0	1950		
BGC0001104.1|Myxovirescin_3 # 1555 # 2808 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.697	BGC0001104.1|Myxovirescin_3 	1555	2808	-	Loose	310	25.409	Type B NfxB	29.55	3004060	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCACCTCACCTGTGCAGGAGCTGGTTGTCTCGGGGTTCGGGGTCACCTCCGCCATTGGCCAGGGGGCCGCGTCCTTCACCTCGGCGCTGCTGGAGGGCGCGGCACGGTTCCGGGTGATGGAGCGGCCGGGCCGTCAGCATCAGGCCAACGGGCAGACGACGGCCCACCTGGGGGCGGAAATCGCCTCGCTGGCCGTGCCCGAAGGCGTCACCCCACAACTGTGGCGCTCGGCCACGTTTTCGGGGCAGGCCGCACTGGTGACCGTCCACGAGGCCTGGAACGCGGCGCGCCTCCAGGCCGTCCCCGGACACCGGATTGGATTGGTGGTGGGGGGCACCAACGTGCAGCAGCGCGACCTGGTGCTGATGCAAGACGCCTATCGCGAGCGGGTGCCCTTTCTGCGGGCGGCCTACGGGTCGACCTTCATGGACACCGACCTCGTGGGCCTCTGCACGCAGCAGTTCGCCATCCACGGGATGTCCTTCACGGTGGGAGGCGCATCGGCCAGTGGCCTGCTGGCGGTCATCCAGGCCGCGGAGGCGGTGCTCTCAAGAAGGGTGGACGTTTGCATCGCCGTGGGGGCGCTGATGGACGTCTCCTACTGGGAATGCCAGGGCCTGCGGGCCATGGGCGCGATGGGCACCGACCGGTTCGCGCGGGAGCCGGAGCGTGCCTGCCGGCCCTTCGACCGGGAGAGTGATGGCTTCATCTTTGGAGAGGCGTGCGGCGCCGTGGTGGTTGAGTCTGCGGAGCACGCTCGGCGACGCGGGGTGACTCCTCGCGGCATCCTGTCGGGCTGGGCCATGCAGTTGGACGCGAGCCGCGGCCCGTTGTCGTCCATCGAAGGGGAGTCGCAGGTGATTGGGGCTGCGCTGCGGCACGCGGACCTCGCGCCGGAGCGGGTGGACTACGTGAATCCTCACGGCAGCGGTTCGCGTCAGGGGGATGCCATCGAGCTGGGGGCCTTGAAGGCGTGCGGCCTGACGCACGCCCGGGTCAACACCACGAAGTCCATCACCGGGCATGGCCTGTCCTCGGCGGGTGCCGTGGGGCTCATCGCCACGCTGGTCCAGTTGGAGCAGGGCCGGCTGCACCCGTCCTTGAACCTGGTGGACCCGATTGATTCATCGTTCCGCTGGGTGGGGGCCACCGCGGAGGCCCAGTCCCTCCAGAACGCGCTGGTGCTCGCCTACGGCTTCGGCGGCATCAACACCGCTGTCGCCGTGCGCCGGAGCGCCACGGAGAGCTGA	MSTSPVQELVVSGFGVTSAIGQGAASFTSALLEGAARFRVMERPGRQHQANGQTTAHLGAEIASLAVPEGVTPQLWRSATFSGQAALVTVHEAWNAARLQAVPGHRIGLVVGGTNVQQRDLVLMQDAYRERVPFLRAAYGSTFMDTDLVGLCTQQFAIHGMSFTVGGASASGLLAVIQAAEAVLSRRVDVCIAVGALMDVSYWECQGLRAMGAMGTDRFAREPERACRPFDRESDGFIFGEACGAVVVESAEHARRRGVTPRGILSGWAMQLDASRGPLSSIEGESQVIGAALRHADLAPERVDYVNPHGSGSRQGDAIELGALKACGLTHARVNTTKSITGHGLSSAGAVGLIATLVQLEQGRLHPSLNLVDPIDSSFRWVGATAEAQSLQNALVLAYGFGGINTAVAVRRSATES	MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS	222.99	gnl|BL_ORD_ID|2404|hsp_num:0	2693		
